Sodium 4-(4-chloro-2-hydroxybenzamido)butanoate

Catalog No. :
ACQDUE408
CAS No. :
387825-07-2
Molecular Formula :
C11H11ClNNaO4
Molecular Weight :
279.65

IUPAC Name:sodium 4-(4-chloro-2-hydroxybenzamido)butanoate

Sodium 4-(4-chloro-2-hydroxybenzamido)butanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$65.00Login to see priceIn stockIn stock
5g95%$224.00Login to see priceIn stockIn stock
25g95%$964.00Login to see priceIn stockInquiry
100g95%$3573.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium 4-(4-chloro-2-hydroxybenzamido)butanoate
IUPAC Namesodium 4-(4-chloro-2-hydroxybenzamido)butanoate
Molecular FormulaC11H11ClNNaO4
Molecular Weight279.65
SMILESO=C([O-])CCCNC(C1=CC=C(Cl)C=C1O)=O.[Na+]
InChI KeyUQFYDAAKCZKDHS-UHFFFAOYSA-M
SynonymSalclobuzate sodium;Sodium 4-(4-chloro-2-hydroxybenzamido)butanoate;Salclobuzate sodium (4-CNAB)
CAS No.387825-07-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACQDUE408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCPDH052 route compound structure diagram
    ACCPDH05256-12-2 In Stock
  2. Plus
  3. ACDHJY746 route compound structure diagram
    ACDHJY7465106-98-9 In Stock
  4. Then
  5. ACQDUE408 route product structure diagram
    ACQDUE408387825-07-2 In Stock
Inquiry

2. ACQDUE408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCPDH052 route compound structure diagram
    ACCPDH05256-12-2 In Stock
  2. Plus
  3. ACDHJY746 route compound structure diagram
    ACDHJY7465106-98-9 In Stock
  4. Then
  5. ACQDUE408 route product structure diagram
    ACQDUE408387825-07-2 In Stock
Inquiry

Comments (0)